Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eisai
Eisai
Why Alzheimer's Treatment Hopes Endure Despite High-Profile Drug Failures
Investors Business Daily
Sat, 06/15/19 - 05:44 pm
Alzheimer's disease
drug development
Biogen
Eisai
Alzheimer’s R&D projects sidelined as Biogen’s aducanumab shock shakes researchers to the core of their beliefs
Endpoints
Tue, 05/14/19 - 09:56 am
Alzheimer's disease
drug development
aducanumab
Biogen
Eisai
BAN2401
Merck
Eli Lilly
AstraZeneca
New Eisai venture arm to focus on digital tech, dementia, cancer
BioCentury
Fri, 05/10/19 - 06:02 pm
Eisai
venture capital
dementia
digital technology
cancer
Eisai Continues Alzheimer's Research, Adds 2 Alzheimer's Pros as Execs
BioSpace
Sun, 05/5/19 - 10:36 am
Eisai
Biogen
Alzheimer's disease
R&D
aducanumab
BAN2401
After A Big Failure, Scientists And Patients Hunt For A New Type Of Alzheimer's Drug
NPR
Sat, 05/4/19 - 02:35 pm
Alzheimer's disease
R&D
drug development
beta amyloid
Biogen
Eisai
aducanumab
Eisai buys Purdue stake in insomnia drug as PDUFA date nears
Fierce Biotech
Wed, 05/1/19 - 10:46 am
Eisai
Purdue Pharma
insomnia
lemborexant
FDA
Is a severely damaged Biogen looking to shed its ties to a controversial development partner?
Endpoints
Sat, 03/23/19 - 12:07 pm
Biogen
Eisai
Alzheimer's disease
BAN2401
RIP amyloid beta theory? Nope. Biogen partner launches a new PhIII before aducanumab's corpse turned cold
Endpoints
Fri, 03/22/19 - 11:58 am
Biogen
Eisai
BAN2401
Alzheimer's disease
clinical trials
Biogen halts Alzheimer's drug trials in 'transformative' failure for the biotech
BioPharma Dive
Thu, 03/21/19 - 09:56 am
Biogen
Eisai
Alzheimer's disease
clinical trials
aducanumab
Eisai, Takeda and GARDP hunt for new antibiotics
Pharmaforum
Wed, 12/12/18 - 09:54 am
Eisai
Takeda
GARDP
antibiotics
R&D
Eisai, UCL to launch phase I trials of E2814 for Alzheimer’s disease
Pharmaceutical Business Review
Mon, 12/10/18 - 01:15 pm
Eisai
Alzheimer's disease
E2814
clinical trials
University College London
Careful, reps: Doctors are watching, FDA promo police's latest rebuke shows
Fierce Pharma
Tue, 10/30/18 - 12:15 pm
FDA
drug reps
physicians
Eisai
Fycompa
drug marketing
Biogen’s ‘positive’ Alzheimer’s trial has a problem with small numbers
Stat
Thu, 10/25/18 - 11:31 am
Biogen
Eisai
BAN2401
Alzheimer's disease
Sleep Well, Wake Up Alert: Eisai and Purdue's Lemborexant Positive in Phase III Trial for Insomnia
BioSpace
Wed, 10/17/18 - 10:23 am
Eisai
Purdue Pharma
lemborexant
insomnia
Bial and Eisai confirm effectiveness of epilepsy monotherapy Zebinix
Pharmaceutical Business Review
Tue, 10/9/18 - 09:49 am
Bial
Eisai
Zebinix
epilepsy
focal-onset epilepsy
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
CP Wire
Wed, 09/5/18 - 10:15 am
China
Eisai
Merck
Lenvima
liver cancer
HCC
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
Wed, 09/5/18 - 09:25 am
Eisai
Merck
Lenvima
liver cancer
hepatocellular carcinoma
Biogen and Eisai Report Phase Ib Extension Data for Alzheimer’s Trial
BioSpace
Tue, 08/28/18 - 07:54 pm
Biogen
Eisai
aducanumab
clinical trials
Alzheimer's disease
Eisai's weight-loss drug proves safe, but delivers no heart benefit
Biopharma Dive
Mon, 08/27/18 - 10:45 pm
Eisai
Belviq
New England Journal of Medicine
European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade
CP WIre
Thu, 08/23/18 - 10:20 am
Eisai
Merck
Lenvima
hepatocellular carcinoma
Europe
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »